Detalles de la búsqueda
1.
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study.
Clin Endocrinol (Oxf)
; 86(5): 725-730, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28092404
2.
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action.
Gynecol Endocrinol
; 33(9): 698-701, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28434274
3.
Neuroendocrine Regulation of Food Intake in Polycystic Ovary Syndrome.
Reprod Sci
; 25(5): 644-653, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28874103
4.
Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down's syndrome.
Menopause
; 23(11): 1247-1251, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27465716
5.
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
Eur J Endocrinol
; 175(5): 433-41, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511825
6.
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation.
Diabetes Care
; 36(6): 1477-82, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23315599
7.
Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women.
Fertil Steril
; 95(1): 158-63, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20728082
Resultados
1 -
7
de 7
1
Próxima >
>>